<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Understanding Psilocybin</title>
    <meta name="description" content="Comprehensive guide to understanding the policy models for legalizing psilocybin">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Asap+Condensed:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Asap+Condensed:ital,wght@0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Bebas+Neue&family=Montserrat:ital,wght@0,100..900;1,100..900&family=Roboto+Condensed:ital,wght@0,100..900;1,100..900&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="css/style.css">
</head>

<body>
    <header class="header">
        <div class="container">
            <h1 class="main-title">Understanding Psilocybin</h1>
            <p class="body-text">
                As states across the U.S. explore how to legalize 
                and regulate psilocybin, eight distinct policy models 
                have emerged. This matrix outlines these options—ranging 
                from FDA-approved use to state-run monopolies to help 
                identify promising paths toward making psychedelic-assisted 
                mental health treatment more accessible.
            </p>
            <h3 class="subheading"> An <a href="https://github.com/goinvo/understanding-psilocybin">opensource</a> work by <a href="goinvo.com">GoInvo</a></h3>
            <h4 class="subheading">v0.1 updated 16 June 2025</h4>
        </div>
    </header>

    <main class="main-content">
         <div class="container"> 
            <!-- Featured Grid -->
           <div class="grid">
            <!-- 9 rows × 7 columns = 63 cells -->
             <!-- Row 1 -->
            <!-- <div class="cell invisible"></div> -->
            <div class="cell invisible"></div>
            <div class="cell invisible">
                <p class="label-text">
                    CT
                </p>
            </div>
            <div class="cell invisible">
                <p class="label-text">
                    MN
                </p>
            </div>
            <div class="cell invisible">
                <p class="label-text">
                    VT
                </p>
            </div>
            <div class="cell invisible">
                <p class="label-text">
                    NV
                </p>
            </div>
            <div class="cell invisible">
                <p class="label-text">
                    WA
                </p>
            </div>
            <!-- Row 2 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">1.</span> Deprioritization/ Decriminalization
                </p>
            </div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>
            <div class="cell shadow0">N/A</div>
            <!-- Row 3 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">2.</span> Non-Commercial Peer Sharing 
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <!-- Row 4 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">3.</span> Commercial Sales
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>
            <!-- Row 5 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">4.</span> Religious Use Exemptions
                </p>
            </div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow2">Supported</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow1">Endorsed</div>
            <!-- Row 6 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">5.</span> Supervise Adult Use
                </p>
            </div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>
            <!-- Row 7 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">6.</span> Medical/ Therapeutic Use
                </p>
            </div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow3">Mixed</div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow1">Endorsed</div>
             <!-- Row 8 -->
            <!-- <div class="cell"></div> --> 
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">7.</span> FDA-Approved Use
                </p>
            </div>
            <div class="cell shadow1">Endorsed</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow5">Opposed</div>
            <div class="cell shadow5">Opposed</div>
            <!-- Row 9 -->
            <!-- <div class="cell"></div> -->
            <div class="cell invisible">
                <p class="label-text">
                <span class="label-number">8.</span> State Monopoly Sales
                </p>
            </div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            <div class="cell shadow0">N/A</div>
            </div>
        <!-- Mobile Layout -->
        <div class="mobile-grid">
        <!-- Deprioritization/Decriminalization -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">1.</span> Deprioritization/Decriminalization</div>
                <div class="state-row-group">
                  <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                  <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                  <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                  <div class="state-row"><span class="state-label">NV</span><span class="state-value2">Supported</span></div>
                  <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
        <!-- Non-Commercial Peer Sharing -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">2.</span> Non-Commercial Peer Sharing</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
        <!-- Commercial Sales -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">3.</span> Commercial Sales</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value2">Supported</span></div>
                </div>
            </div>
         <!-- Religious Use Exemptions -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">4.</span> Religious Use Exemptions</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value2">Supported</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
        <!-- Supervised Adult Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">5.</span> Supervised Adult Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
        <!-- Medical/Therapeutic Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">6.</span> Medical/Therapeutic Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value3">Mixed</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value1">Endorsed</span></div>
                </div>
            </div>
         <!-- FDA-Approved Use -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">7.</span> FDA-Approved Use</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value1">Endorsed</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value5">Opposed</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value5">Opposed</span></div>
                </div>
            </div>
        <!-- State Monopoly Sales -->
            <div class="category-block">
                <div class="category-label"><span class="label-number">8.</span> State Monopoly Sales</div>
                <div class="state-row-group">
                    <div class="state-row"><span class="state-label">CT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">MN</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">VT</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">NV</span><span class="state-value0">N/A</span></div>
                    <div class="state-row"><span class="state-label">WA</span><span class="state-value0">N/A</span></div>
                </div>
            </div>
            </div>
        </div>
    </main>
    <header class="header">
        <div class="container">
            <h2 class="main-title">Help us make this real.</h2>
            <p class="body-text">
                We need feedback, funding, and a few brave new allies. <br>
                Send us your feedback at <a href="up@goinvo.com">up@goinvo.com</a>
            </p>
            <h2 class="main-title">References</h2>
            <ol class="body-text">
              <li>
                BrainFutures. <em>Psychedelic Pathways Report</em>. 2023. 
                <a href="reports/brainfutures-psychedlic-pathways-v3.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Connecticut Department of Mental Health and Addiction Services. <em>Psilocybin Study Final Report</em>. 2023. 
                <a href="reports/CT-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Minnesota Department of Health. <em>Psychedelic Medicine Task Force Report</em>. 2024. 
                <a href="reports/MN-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Nevada State Legislature. <em>Psilocybin Working Group Final Report</em>. 2024. 
                <a href="reports/NV-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Pacula, Rosalie Liccardo, et al. “Current Models of Psilocybin Regulation.” RAND Corporation, 2023. 
                <a href="reports/RAND_RRA2825-1 (1).pdf" target="_blank">PDF</a>
              </li>
              <li>
                Vermont Department of Health. <em>Psychedelic Therapy Report</em>. 2024. 
                <a href="reports/VT-Report.pdf" target="_blank">PDF</a>
              </li>
              <li>
                Washington State Health Care Authority. <em>Psychedelic Work Group Final Report</em>. 2023. 
                <a href="reports/WA-Report.pdf" target="_blank">PDF</a>
              </li>
            </ol>
        </div>
    </header>
<script src="script.js"></script>
  <footer class="site-footer">
  <p><a href="goinvo.com">&copy; GoInvo</a> Open source under Creative Commons Attribution v4.</p>
</footer>
</body>
</html>



